This stock has been at the top of our buy list since February. Despite Adma Biologics (Nasdaq: ADMA) gaining 78% in the past few months the share price still has room for near-term growth. Luckily, … [Read more...] about MS Number 1 Pick For April 2019
Articles
MS Swing Move #Focused
Nasdaq: EYPT) Eyepoint Pharmaceuticals #focus by follow_the_money on TradingView.com This past week Eyepoint Pharmaceuticals filed form 4's three days in a row. Interestingly, this week Eyepoint … [Read more...] about MS Swing Move #Focused
Corbus Pharmaceuticals Has A New Board Member
A press release today from Corbus Pharmaceuticals (Nasdaq: CRBP) announced the addition of Rachelle Jaques to the board of directors. After this appointment CRBP's board consists of 7 highly qualified … [Read more...] about Corbus Pharmaceuticals Has A New Board Member
Eye-Catching Results at AACR 2019: A Quick Road Map
In a new series for MS Money Moves Premium Members, Chris Stang a PharmD candidate at the University of Findlay and Nationwide Pharmacy Intern will evaluate a few pieces of data releases from health … [Read more...] about Eye-Catching Results at AACR 2019: A Quick Road Map
Two Biotech Stocks We Are Watching For Entry
The past two weeks have been tumultuous for the markets and biotech was not insulated. With the sell-off comes opportunities to buy cheap and sell into the recovery which I believe began last week. … [Read more...] about Two Biotech Stocks We Are Watching For Entry
Evaluating the Merits of AVEO’s Potential Purchase
At the end of January, the small-cap biotechnology company AVEO Oncology (AVEO) updated investors on the delayed timeline for filing with FDA for their lead compound tivozanib. This news led to a … [Read more...] about Evaluating the Merits of AVEO’s Potential Purchase
